Clive Kearon, Michael J Kovacs, Jim A Julian

Slides:



Advertisements
Similar presentations
Results: 1.Progression of thrombus length and volume (40% vs. 28%; P
Advertisements

Thank You This PowerPoint document contains the images that you requested. Copyright Notice All Online Service materials, including, without limitation,
LIFEBLOOD THE Thrombosis CHARITY Venous thromboembolism – Treatment and secondary prevention Ulcus cruris Chronic PE PE DVT Post-thrombotic syndrome Death.
The Current Role of Operative Venous Thrombectomy in Deep Vein Thrombosis Anthony J. Comerota Seminars in Vascular Surgery Volume 25, Issue 1, Pages 2-12.
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Date of download: 9/17/2016 From: Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of d- Dimer Testing.
Management of Deep Vein Thrombosis and Pulmonary Embolism by Jack Hirsh, and John Hoak Circulation Volume 93(12): June 15, 1996 Copyright © American.
Volume 355, Issue 9212, Pages (April 2000)
Volume 134, Issue 3, Pages (September 2014)
The relationship between maintenance dosages of three vitamin K antagonists: Acenocoumarol, warfarin and phenprocoumon  Yvonne van Leeuwen, Frits R. Rosendaal,
Volume 136, Issue 4, Pages (October 2015)
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international,
Pharmacogenetics and future drug development and delivery
Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 
Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention.
Volume 101, Issue 7, Pages (July 2007)
Volume 376, Issue 9734, Pages (July 2010)
Volume 373, Issue 9679, Pages (June 2009)
Thank God for Richard Dawkins?
Russell D. Hull, MBBS, MSc, Graham F. Pineo, MD, Rollin F
Fetal growth and ethnic variation
Statins, electron-beam CT, and aortic-valve calcification
Neonatal vitamin A: time to move on?
Timothy A. Brighton, M. B. , B. S. , John W. Eikelboom, M. B. , B. S
Author gender in The Lancet journals
Infections related to totally implantable venous-access ports
Intraoperative radiotherapy for early breast cancer
Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis  Juan Francisco Sanchez Muñoz-Torrero,
Volume 376, Issue 9734, Pages (July 2010)
Venous Thromboembolism with Chronic Liver Disease
Volume 382, Issue 9891, Pages (August 2013)
Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study  Nicolas Faller, MD, PhD,
Aspirin in the prevention of cancer – Author's reply
Volume 356, Issue 9241, Pages (November 2000)
Russell D. Hull, MBBS, MSc, Graham F. Pineo, MD, Rollin F
Theo Nicholaou, Rachel Wong, Ian D Davis  The Lancet 
Volume 373, Issue 9663, Pages (February 2009)
Influence of Renal Function on the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Non–Vitamin K Antagonist Oral Anticoagulants  Matthew R.
Volume 373, Issue 9679, Pages (June 2009)
Volume 365, Issue 9466, Pages (April 2005)
Adjuvant chemotherapy for rectal cancer – Authors' reply
Physiological hazards of flight at high altitude
Meta-analysis of randomised controlled trials
Carlos Aguilar, MD, Valentin del Villar, MD 
HIV myths should not be resuscitated
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts  Prof.
Michael J Goldacre, Jenny J Maisonneuve  The Lancet 
P. Jothishankar, S. Maikandanathan, S.C. Hardy, R.A. Salaman 
CCR5-Δ32 gene deletion in HIV-1 infected patients
Confessions of a journal junkie
Errata The Lancet Infectious Diseases
Volume 371, Issue 9627, Pages (May 2008)
Telling it like it isn't: truth and lies in a post-9/11 world
Iran, sanctions, and collaborations
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study  Heart Protection.
Thank God for Richard Dawkins?
Department of Error The Lancet Volume 369, Issue 9564, (March 2007)
Low-technology approaches
Prescription for change
Volume 373, Issue 9672, Pages (April 2009)
Fetal growth and ethnic variation
Infections related to totally implantable venous-access ports
Sputum culture conversion in new TB regimens
Volume 1, Issue 2, Pages (July 2014)
Tapestry of life The Lancet Volume 375, Issue 9723, (April 2010)
Living in colour—American children, race, and wellbeing
Pleurodesis for primary spontaneous pneumothorax – Authors' reply
Autism, maths, and sex: the special triangle
Reversible biological adaptations in obesity
A disease of the osteoblast
Presentation transcript:

Clive Kearon, Michael J Kovacs, Jim A Julian Deep vein thrombosis  Clive Kearon, Michael J Kovacs, Jim A Julian  The Lancet  Volume 366, Issue 9480, (July 2005) DOI: 10.1016/S0140-6736(05)66858-4 Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure Cumulative probability of recurrent venous thromboembolism, episode of major bleeding, or death in patients with unprovoked venous thrombosis who were assigned to low-intensity or conventional-intensity warfarin after at least 3 months of initial conventional-intensity anticoagulation Previously unpublished analysis and not based on an a-priori hypothesis. Hazard ratio 0·54 (95% CI 0·31–0·95). The Lancet 2005 366, DOI: (10.1016/S0140-6736(05)66858-4) Copyright © 2005 Elsevier Ltd Terms and Conditions